Teladoc Health, Inc. (TDOC) Institutional Ownership & Insider Trading

347 institutions reported holding Teladoc Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 39 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

TDOCTeladoc Health, Inc.Follow TDOC — free

Health Information Services · Healthcare

—

Price chart with a free account

Market cap: 1.2B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 28 Oct, in 4 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

347 institutions held 83.9% of the shares. Across filers that reported both quarters, shares held changed +7.0%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	347	152	+7.0%	97	48	84	31
Mar 26	321	142	+10.2%	107	46	72	57
Dec 25	335	132	+6.5%	91	30	112	41
Sep 25	342	124	-2.8%	98	41	89	44
Jun 25	351	128	+1.9%	98	41	105	59
Mar 25	368	125	-1.1%	112	46	94	40
Dec 24	370	127	-0.4%	102	39	95	47
Sep 24	353	125	-8.8%	81	45	120	85

Teladoc Health, Inc. — questions

Who owns Teladoc Health, Inc. stock?: 347 institutions reported Teladoc Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.9%), VANGUARD PORTFOLIO MANAGEMENT LLC (7.0%), Point72 Asset Management, L.P. (4.5%).
Are Teladoc Health, Inc. insiders buying or selling?: 39 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Teladoc Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.